October 2023
The global proteomics market size accounted for USD 36.25 billion in 2024, grew to USD 41.65 billion in 2025 and is predicted to surpass around USD 145.39 billion by 2034, representing a healthy CAGR of 14.90% between 2024 and 2034. The North America proteomics market size is calculated at USD 17.04 billion in 2024 and is expected to grow at a fastest CAGR of 15.01% during the forecast year.
The global proteomics market size is estimated at USD 36.25 billion in 2024 and is anticipated to reach around USD 145.39 billion by 2034, expanding at a CAGR of 14.90% from 2024 to 2034.
The U.S. proteomics market size is evaluated at USD 11.93 billion in 2024 and is predicted to be worth around USD 48.69 billion by 2034, rising at a CAGR of 15.09% from 2024 to 2034.
The largest revenue will be generated in the North American region. Constant research and development in the field and the use of high-quality tools for research purposes will lead to the growth of this market. The growing need for personalized medicines or tailor-made treatments will show up significant growth in the coming years due to which the need for proteomics will grow. Constant collaborations and partnerships amongst the market players will also help in the growth of this market. The Asia Pacific region will also show significant growth in the coming years as many projects that are proteomics based are outsourced to the countries in the Asia Pacific region. Government regulations in these regions are favorable due to which there's greater adoption of proteomics techniques.
Proteomics is the most evolved field of the diagnosis of the disease which is changing rapidly. Proteomics is used for the identification of the proteins that are present in a particular disease and it helps in understanding their expression structure as well as function. Prognostic markers can also be identified with the proteomic study and it helps in the diagnosis of cancer, malaria, tuberculosis, and different types of infectious diseases. When it comes to the use of proteomics in the industry of drugs it plays a very significant role in the investigation of the mechanical happening or the functioning of the drug. Drug development makes use of proteomics and many proteomic divisions are started by various manufacturers in order to increase their efficiency. The proteomics market is expected to grow well during the forecast period.
Many important contributions have been made by proteomic research in the field of personalized medicines. One of the most promising and effective approaches against cancer is personalized medicines and these medicines are developed with the help of proteomics.
Proteomics plays a very significant role against extremely rare conditions that are genetic and also against neurodegenerative diseases. Significant information about the tumor in a person and the planning of the treatment can be made with the help of proteomics which helps in the making of the personalized diseases which can be prescribed depending upon the condition of the patient.
Personalized therapy has grown significantly and the demand for this kind of therapy is expected to grow even in the coming years due to which the demand for proteomics will also grow during the forecast period. Advanced kind of protein interactions has played an extremely significant role in the making of personalized medicines. There are many applications of proteomics, especially in the field of nanotechnology. It has applications like nanostructured surfaces which are for protein separation and metal oxide nanoparticles. The recently emerging field of nano proteomics is expected to grow significantly in the coming years and provide major opportunities for the growth of the market during the forecast period.
In the future, many new technologies are expected to be incorporated into proteomics due to an increased number of efforts taken in the research and developmental activities through technical and monetary ways. In recent years cases of cancer have increased in the recent years and the number of genetic disorders has also grown to a great extent the demand for proteomics is expected to grow significantly in the coming years. Characterization of the human protein is a major milestone in biomedicine which is an extremely new and dynamic type of science that focuses majorly on the understanding of gene expression at the level of proteome.
Report Coverage | Details |
Market Size in 2024 | USD 36.25 Billion |
Market Size by 2034 | USD 145.39 Billion |
Growth Rate from 2024 to 2034 | CAGR of 14.90% |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2023 |
Forecast Period | 2024 to 2034 |
Segments Covered |
|
Regions Covered |
|
Depending on the products, the consumables and the reagents segment are expected to have the largest market share in the coming years. Large scale use of the consumables and reagents, chemicals, kits, and strips that are used for the examination in various academic institutes and research labs the need for all of these products will lead to the growth of the segment. Research and development in the field have led to technological advancements and many new advanced instruments are introduced in the market.
These instruments help in increasing the speed as well as the efficiency of the process. It also plays a significant role in the outcome of biological research. Some of the most commonly used equipment are biochip analyzers and electrophoresis equipment. Due to constant advancement in the techniques used for automation, it is also in great demand as this is offered as a cost-effective way for analysts. The use of biochips is another breakthrough that has led to significant growth in the market. Innovative equipment introduced in the market we will prove to be a boon for the growth of this market in the long run.
The segment of clinical diagnostics will have the largest market share in the coming years and the segment has dominated the market in the past with a share of about 53% in terms of revenue. Increased use of the method of proteomics for the identification of various diseases will lead to the growth of the market in the coming years. Diseases are detected earlier which also helps in removing the risk of mortalities. This method also helps in understanding the risk factors. Early detection of various diseases will prove to be a major opportunity for the growth of this technique in the coming years. Understanding potential biomarkers can be identified through the help of proteomics. It also helps in the identification and classification of tumors.
The drug discovery segment is also expected to show significant growth and it will expand at the fastest compound annual growth rate in the coming years. Drug design that is structure-based will be developed and it will provide major growth in the market. Growing demand for personalized drugs has also played a significant role in the growth of the market. Many new investments are seen in this field which are mainly due to the growing demand for personalized drugs. Early detection of various diseases also helps in the need for drugs. Drug discovery processes are enhanced due to the use of proteomics technology and it also helps in saving a lot of time for pharmaceutical companies. A lot of amounts of capital that is spent on this process can also be reduced due to the use of this technology. The healthcare system as well as the patients benefit due to this technology.
Depending on the technology, the spectroscopy segment is expected to have the largest market share and it will generate maximum revenue. The extensive use of this technology for most of the processes and major applications of this technology in the development of drugs foreign sick analysis pharmaceutical analysis and proteomics metabolomics will lead to the growth of the market. This is one of the most widely used methods and it has grown significantly in recent years as it helps in the formation of drugs through various processes. The market growth will be supplemented due to the use of microarray techniques. The use of this analysis in antibiotic therapy is successful and this will play an instrumental role in the growth of the market. Microarrays that are DNA based are mostly preferred for the identification of gene expression. It helps in cost reduction and it also reduces the amount of complexity. This is the most widely used and available technology.
By Product
By Application
By Technology
By Software & Service
By End User
By Geography
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
October 2023
June 2024
October 2023
July 2024